Compliance Epilepsy Sleep 
United Patients Group
JULY 7, 2023
While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.
Miss Marijuana
JANUARY 31, 2025
Epilepsy and Seizure Disorders Seizures are one of the most unpredictable and frightening symptoms for people with epilepsy and other seizure disorders. People with epilepsy are finding that adding cannabis to their treatment plan provides more stability and control over their condition.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 12, 2022
Tammy Tam, co-founder of CBD beer brand plantB, said her company only uses products that are certified THC-free and “go beyond the government compliance level.”. Many consumers use CBD in hopes of improving sleep, treating pain and bettering general wellbeing.
Cannabis Chronicles
FEBRUARY 15, 2019
The products made in Fairwinds’ east Vancouver headquarters have names such as “Deep Sleep,” “Digestify” and “AM Relief” that hint at the possible effects of each product. Cannabis companies, like Fairwinds, would have until January 2020 to submit packaging and labeling in compliance with the new requirements or remove them from the market.
MMJ Recs
NOVEMBER 17, 2023
MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more. Seizure Control: For patients with epilepsy and seizure disorders, certain cannabis-based treatments have shown remarkable effectiveness in reducing the frequency and severity of seizures.
Cannabis Law Report
AUGUST 19, 2021
– ‘Pandemic increased demand’ – “The pandemic increased CBD demand because there obviously were stress, sleep problems, anxiety, these kind of risks,” ACI co-founder Steve Moore told AFP. That was almost a third higher than the UK trade group’s pre-pandemic 2019 projection.
MMJ Recs
MAY 25, 2024
Additionally, the ECS influences sleep patterns, memory, and cognition, supporting optimal brain function. However, dysregulation of the endocannabinoid system has been implicated in the pathogenesis of neurological disorders such as epilepsy, multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease.
Expert insights. Personalized for you.
105 
Let's personalize your content